Current trend of surgery in juvenile nasopharyngeal angiofibroma: a hospital based retro-prospective study

Sachin Jain, Dinesh Kumar, Shivendra P. Singh, Ved P. Upadhyay, Himani N. Singh, Abhishek K. Dubey


Background: The aim of the present study was to know the current trends of surgery, to determine the surgery of choice according to stage and complications, rate of recurrence of following surgery.

Methods: Retro-prospective study was carried out from August 2004 to July 2014, in which 31 prospective and 8 prospective cases were included. All the details of patients like general examination, ENT examination, computed tomography or magnetic resonance imaging scan finding, staging, and approach of surgery, complications, and recurrence rate were recorded. 

Results: In our study all the patients were male and the mean age was 15.74 years (age ranged 11 to 22 years). Most frequent sign and symptoms were epistaxis (92.4%), nasal blockage (90%), and facial swelling (18%). Most common surgical approach was ‘trans palatine approach’ (51% cases) belongs to stage IIa, IIb, IIc, IIIa, IIIb and ‘lateral rhinotomy approach’ used in 35% cases. And by endoscopic approach (only 5.1% cases) were operated due to lack of embolization technique. Overall recurrence was about 29% (66% cases belonged to stage III). Postoperative complications were septal perforation 33%, palatal perforation 9.5%, facial disfiguration 9.5% and 9.5% hypertrophic scar.

Conclusions: Our study we concluded that, 92% of patients age group 11 to 20 years and all were males. Epistaxis and nasal obstruction were the most common symptoms. Most of the recurrent tumor belonged to stage III tumor. Most appropriate surgical approach for stage I, IIa and IIb was transpalatine approach and for stage IIc and IIIa was lateral rhinotomy. Complete excision of intracranial extension of tumor was difficult and causes recurrence of diseases.


Transpalatine, Lateral rhinotomy, Embolization

Full Text:



Golhar M, Rashid D, Ahmed B. Common presenting symptoms diagnosis and management of angiofibroma- a study of twenty cases. Pak J Med Sci. 2004;20:377-80.

Park CK, Kim DG, Paek SH, Chung HT, Jung HW. Recurrent juvenile nasopharyngeal angiofibroma treated with gam¬ma knife surgery. J Korean Med Sci. 2006;21:773-7.

Gleeson M. Juvenile angiofibroma. In: Gilbert RW, Gleeson M, Scott-Brown WG, eds. Scott-Brown's Otorhinolaryngology Head and Neck Surgery. Hodder Arnold; 2008: 2237-2245.

Onerci M, Ogretmenoglu O, Yucel T. Juvenile nasopharyn¬geal angiofibroma: a revised staging system. Rhinol. 2006;44:39-45.

Quinn FB, Ryan MW, Ulualp S. Juvenile nasopharyngeal angiofibroma. Grand Rounds Presentation, UTMB Department of Otolaryngology Head and Neck Surgery; 2007

Marshall AH, Bradley PJ. Management dilemmas in the treatment and follow-up of advanced juvenile nasopharyngeal angiofibroma. ORL J Otorhinolaryngol Relat Spec. 2006;68(5):273-8.

McAfee WJ, Morris CG, Amdur RJ, Werning JW, Mendenhall WM. Definitive radiotherapy for juvenile nasopharyngeal. Am J Clin Oncol. 2006;29(2):168-70.

Chakraborty S, Ghoshal S, Patil VM, Oinam AS, Sharma SC. Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience. Int J Radiat Oncol Biol Phys. 2011;80(5):1398-404.

Reddy KA, Mendenhall WM, Amdur RJ, Stringer SP, Cassisi NJ. Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol. 2001;22(3):172-5.

Ruiz JW, Saint-Victor S, Tessema B, Eloy JA, Anstead A. Coblation assisted endoscopic juvenile nasopharyngeal angiofibroma resection. Int J Pediatr Otorhinolaryngol. 2012;76(3):439-42.

Witt TR, Shah JP, Sternberg SS. Juvenile nasopharyngeal angiofibroma. A 30 year clinical review. Am J Surg. 1983;146(4):521-5.

Spector JG. Management of juvenile angiofibromata. Laryngoscope. 1988;98(9):1016-26.

Schiff M. Juvenile nasopharyngeal angiofibroma: a theory of pathogenesis. Laryngoscope. 1959;69:981-1016.

Dare AO, Gibbons KJ, Proulx GM, Fenstermaker RA. Resection followed by radiosurgery for advanced juvenile nasopharyngeal angiofibroma: report of two cases. Neurosurg. 2003;52(5):1207-11.

Park CK, Kim DG, Paek SH, Chung HT, Jung HW. Recurrent juvenile nasopharyngeal angiofibroma treated with gamma knife surgery. J Korean Med Sci. 2006;21(4):773-7.

Gaillard AL, Anastácio VA, Piatto VB; Maniglia JV, Molina FD. Braz J Otorhinolaryngol. 2010;76(2):245-50.

Andrade NA, Andrade JSC, Silva PDM, Oliveira VB, Andrade BB. Nasopharyngeal angiofibroma: review of the genetic and molecular aspects. Intl Arch Otorhinolaryngol. 2008;12:442-9.

Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Juvenile nasopharyngeal angiofibroma: Review article. J HK Coll Radiol. 2003;6:15-9.

Schick B, Wemmert S, Jung V, Steudel WI, Montenarh M, Urbschat S. Genetic heterogeneity of the MYC onco¬gene in advanced juvenile angiofibromas. Cancer Genet Cytogenet. 2006;164:25-31.

Tang IP, Shashinder S, Gopala Krishnan G, Narayanan P. Juvenile nasopharyngeal angiofibroma in a tertiary cen¬tre: ten-year experience. Singapore Med J. 2009;50 (3):261-4.

Midilli R, Karci B, Akyildiz S. Juvenile nasopharyngeal angiofibroma: analysis of 42 cases and important aspects of endoscopic approach. Int J Pediatric Otorhinolaryngol. 2009;73(3):401-8.

Herman P, Lot G, Chapot R, Salvan D, Huy PT. Long-term follow-up of juvenile nasopharyngeal angiofibromas: analysis of recurrence. Laryngoscope. 1999;109(1):140-7.

McCombe A, Lund VJ, Howard DJ. Recurrence in juvenile angiofibroma. Rhinol. 1990;28(2):97-102.

Leong SC. A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. Laryngoscope. 2013;123(5):1125-31.

Hosseini SM, Borghei P, Borghei SH, Ashtiani MT, Shirkhoda A. Angiofibroma: an outcome review of conventional surgical approaches. Eur Arch Otorhinolaryngol. 2005;262(10):807-12.

Tuna EU, Karaca C, Kaymakci M, Ozbek C, Ozdem C. Transpalatal approach in juvenile nasopharyngeal angiofibroma. Kulak Burun Bogaz Ihtis Derg. 2007;17(1):7-12.